Invesaro

Stocks MIND Financial statements

Financial statements

MIND TECHNOLOGY, INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MIND TECHNOLOGY, INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue4148.342.942.721.223.12536.546.940.9
Cost of revenue48.442.231.226.113.917.122.120.525.922.3
Gross profit-7.416.0811.7137.316.029.95162118.7
Research and development0.971.51.161.8533.61.372.131.911.59
Selling, general and administrative19.819.720.914.112.614.812.912.111.313.3
General and administrative20.7
Operating expenses23.925.824.819.221.620.615.615.514.115.8
Operating income-31.3-19.7-13-6.29-14.3-14.5-5.650.526.822.86
Interest expense0.65
Interest income0.01
Other non-operating income-0.05-0.45-6.570.10.860.93-6.09-1.10.24-0.11
Pre-tax income-31.3-20.2-19.6-6.19-13.5-13.6-5.390.247.062.9
Income tax1.810.910.250.350.54-0.040.71.341.982.15
Income from continuing operations-6.54-14-13.6-7.43
Net income-33.2-21.1-19.8-11.3-20.3-15.1-8.830.275.070.75
EBITDA-28.9-17.6-10.5-3.8-11.5-12.3-4.311.77.763.73
EPS, basic-2.79-1.82-1.78-1.10-1.80-1.31-8.98-2.504.320.09
EPS, diluted-2.79-1.82-1.78-1.10-1.80-1.31-0.92-2.504.320.09
Shares, basic (weighted)12.112.112.112.112.513.81.4104.088.26
Shares, diluted (weighted)12.112.112.112.112.513.81.4104.088.33

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents2.99.99.393.094.615.110.785.295.3419.1
Receivables6.624.758.133.26.611.812.6
Inventory1210.910.812.711.5141113.413.711.2
Other current assets2.191.551.741.991.661.841.43.111.222.11
Total current assets35.13336.339.426.829.222.228.332.144.9
Property, plant and equipment43.822.914.25.424.754.270.950.820.891.24
Lease right-of-use assets2.31.471.841.751.321.321.09
Goodwill42.532.532.5300
Intangible assets9.018.0210.58.146.756.023.632.892.311.75
Other non-current assets0.030.930.580.4300.650
Total assets94.773.765.358.239.84232.933.536.749.3
Accounts payable1.931.271.531.771.72.052.491.622.561.21
Accrued liabilities4.515.253.741.572.915.761.482.141.25
Deferred revenue0.650.741.040.730.210.230.140.20.190.32
Short-term debt6.370
Total current liabilities13.57.527.438.457.8410.78.9310.38.657.44
Long-term debt00
Lease liabilities0.960.460.970.850.570.740.41
Other non-current liabilities01.20.970
Total liabilities13.87.838.6210.69.3511.89.8110.99.397.85
Total debt6.370
Paid-in capital121122123124128129130113136149
Retained earnings-20.5-42.4-64-77.3-99.9-118-128-128-108-108
Treasury stock-16.9-16.9-16.9-16.9-16.9-16.9-16.90
Other comprehensive income-10.6-8.85-4.04-4.39-4.36-1.880.030.030.030.03
Shareholders' equity80.965.856.747.730.430.323.122.627.341.4
Total equity80.965.856.747.730.430.323.122.627.341.4
Total liabilities and equity94.773.765.358.239.84232.933.536.749.3
Shares outstanding1.417.979.09

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-33.2-21.1-19.8-11.3-20.3-15.1-8.830.275.070.75
Depreciation and amortization2.42.152.52.492.82.211.341.180.940.87
Stock-based compensation0.740.90.780.850.710.640.650.260.241.55
Deferred income tax0.93-0.02-0.380.27-0-0.11-0.06-0.150.04-0.22
Change in receivables7.354.411.29-1.724.63-3.24.89-3.34-5.25-0.74
Change in inventory0.850.69-0.78-2.811.18-3.07-1.76-3.6-0.442.37
Cash from operations3.150.72-5.46-5.82-6.36-17.1-2.91-4.970.652.59
Capital expenditures-0.28-0.41-0.81-1.04-0.09-0.83-0.57-0.29-0.44-0.66
Acquisitions00-3
Cash from investing4.419-0.02-2.093.215.360.47110.02-0.66
Stock issued0003.580.040011.8
Share buybacks-0000-0-00
Cash from financing-7.31-3.045.151.754.5112.2-1.9-1.54-0.6211.8
Exchange rate effect-0.51-0.04-0.27-0.160.02
Net change in cash-0.266.64-0.6-6.321.380.5-4.344.510.0513.7
Free cash flow2.870.31-6.27-6.85-6.45-18-3.48-5.260.211.92
Interest paid0.670.090.010.060.040.0300.630
Income taxes paid0.410.490.620.50.340.360.370.851.652.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $4.35 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin42.2%Gross profit / revenue.
Operating margin-2.7%Operating income / revenue.
EBITDA margin-0.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-1.9%Pre-tax income / revenue.
Net margin-6.8%Net income / revenue.
FCF margin-11.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin-9.9%Cash from operations / revenue.
Return on equity (ROE)-5.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-5.0%Net income / average total assets.
Return on invested capital (ROIC)-3.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue4.6%Research and development expense / revenue.
SG&A / revenue37.7%Selling, general and administrative expense / revenue.
Stock-based pay / revenue5.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.2%Capital expenditures / revenue.
D&A / revenue2.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-12.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y17.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y14.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-11.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y23.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y20.6%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-58.1%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-51.9%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-85.2%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-97.9%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y297.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y798.6%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y51.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y21.6%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y6.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y34.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y14.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y4.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y104.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y81.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-7.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio6.92xCurrent assets / current liabilities.
Quick ratio4.97x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio2.54x(Cash + short-term investments) / current liabilities.
Liabilities / assets13.6%Total liabilities / total assets.
Working capital$36.7MCurrent assets - current liabilities.
Goodwill and intangibles / assets3.3%(Goodwill + intangible assets) / total assets.
Tangible book value$38.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.74xRevenue / average total assets.
Fixed asset turnover29.9xRevenue / average property, plant and equipment.
Inventory turnover1.91xCost of revenue / average inventory.
Days inventory191 days365 x average inventory / cost of revenue.
Receivables turnover2.31xRevenue / average receivables.
Days sales outstanding158 days365 x average receivables / revenue.
Days payables11 days365 x average accounts payable / cost of revenue.
Cash conversion cycle338 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.26Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$3.83Revenue / diluted weighted shares.
FCF per share-$0.42Free cash flow / diluted weighted shares.
Operating cash flow per share-$0.38Cash from operations / diluted weighted shares.
Book value per share$4.44Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$4.27Tangible book value / shares outstanding.
Cash per share$1.73(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$39.5MShare price x shares outstanding.
Enterprise value$23.7MMarket cap + total debt - cash - short-term investments.
P/S1.14xMarket cap / revenue.
P/B0.98xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.02xMarket cap / tangible book value, when positive.
EV/Sales0.68xEnterprise value / revenue.
FCF yield-9.8%Free cash flow / market cap.
Earnings yield-6.0%Net income / market cap (the inverse of P/E).
What was MIND TECHNOLOGY, INC's revenue in fiscal 2026?

MIND TECHNOLOGY, INC reported revenue of $40.9M for fiscal 2026, 12.6% lower than the year before.

Was MIND TECHNOLOGY, INC profitable in fiscal 2026?

Yes. Net income was $750.0K, a net margin of 1.8%.

How much free cash flow did MIND TECHNOLOGY, INC generate in fiscal 2026?

Cash from operations of $2.6M minus capital expenditures of $663.0K left free cash flow of $1.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MIND TECHNOLOGY, INC